Patent · US Active

Treating sexual desire disorders with flibanserin

US10307420B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

Sprout Pharmaceuticals, Inc. · US

Inventors

Franco Borsini · Bad Waldsee, DE
Kenneth R. Evans · Spring, US

Key dates

Filing date	Sep 10, 2018
Grant date	Jun 4, 2019
Priority date	—
Expiry date	Sep 10, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.